Literature DB >> 8613198

Regulation of angiotensin II type 2 receptor gene by the protein kinase C-calcium pathway.

K Kijima1, H Matsubara, S Murasawa, K Maruyama, N Ohkubo, Y Mori, M Inada.   

Abstract

In the present study, rat angiotensin II type 2 (AT2) receptor expression was upregulated in confluence-arrested PC12 cells compared with expression in proliferating cells. Treatment with cycloheximide inhibited the increase in mRNA levels in confluent cells. The state of growth arrest by serum deprivation was associated with increased expression of the AT2 receptor, which was markedly suppressed by exposure to the active phorbol ester 12-O-tetradecanoylphorbol 13-acetate and the calcium ionophore A23187. Similar inhibitions were also observed in myocytes isolated from neonatal rat heart. The change in AT2 mRNA levels by serum deprivation was due to the increase in the gene transcription rate. The effect of 12-O-tetradecanoylphorbol 13-acetate was mediated through decreases in gene transcription and mRNA stability, whereas A23187 affected mRNA stability. Vasoactive substances with the protein kinase C-calcium pathway, such as norepinephrine and angiotensin II, also downregulated the AT2 mRNA level in myocytes. These findings indicate that the expression of AT2 receptor in PC12 cells is regulated in a growth state-dependent manner, which is involved in confluence-induced new protein synthesis, thus providing a means by which cells can modulate their responsiveness to external angiotensin II stimulus. The activation of protein kinase C or calcium mobilization modifies this regulatory mechanism, suggesting that neurotransmitters or vasoactive substances with the protein kinase C-calcium pathway at least in part affect neuronal activity or blood pressure control by downregulating AT2 receptor expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613198     DOI: 10.1161/01.hyp.27.3.529

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

Review 1.  Novel actions of angiotensin II via its renal type-2 (AT(2)) receptor.

Authors:  R M Carey; Z Q Wang; H M Siragy
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

2.  Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements.

Authors:  C Warnecke; T Willich; J Holzmeister; S P Bottari; E Fleck; V Regitz-Zagrosek
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

3.  RAAS polymorphisms alter the acute blood pressure response to aerobic exercise among men with hypertension.

Authors:  Bruce E Blanchard; Gregory J Tsongalis; Margaux A Guidry; Lisa A LaBelle; Michelle Poulin; Amy L Taylor; Carl M Maresh; Joseph Devaney; Paul D Thompson; Linda S Pescatello
Journal:  Eur J Appl Physiol       Date:  2006-02-09       Impact factor: 3.078

Review 4.  AT2 receptor activities and pathophysiological implications.

Authors:  Luis C Matavelli; Helmy M Siragy
Journal:  J Cardiovasc Pharmacol       Date:  2015-03       Impact factor: 3.105

Review 5.  Angiotensin II AT2 Receptors Contribute to Regulate the Sympathoadrenal and Hormonal Reaction to Stress Stimuli.

Authors:  J M Saavedra; I Armando
Journal:  Cell Mol Neurobiol       Date:  2017-09-07       Impact factor: 5.046

6.  Telmisartan attenuates hydrogen peroxide-induced apoptosis in differentiated PC12 cells.

Authors:  Guan Tao Du; Xuan Ke; Guo Liang Meng; Guang Jun Liu; Hui Ying Wu; Jin Hong Gong; Xiao Dan Qian; Jin Luo Cheng; Hao Hong
Journal:  Metab Brain Dis       Date:  2018-05-03       Impact factor: 3.584

Review 7.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Authors:  Lauren B Arendse; A H Jan Danser; Marko Poglitsch; Rhian M Touyz; John C Burnett; Catherine Llorens-Cortes; Mario R Ehlers; Edward D Sturrock
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.